Trade IMRN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Immuron Limited American Depositary Shares (IMRN) is trading at US$1.08, down 2.70% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$9.04M. Over the past 52 weeks, IMRN has traded between US$0.68 and US$2.39. On Syfe you can trade IMRN with $0 commission and add it to your watchlist.
| Previous close | US$1.11 |
|---|---|
| Market cap | US$9.04M |
| 52-week range | US$0.68 – US$2.39 |
| Volume | 10.64K |
| Exchange | US |
Immuron Limited American Depositary Shares
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments. The Hyper-immune Products segment includes income and expenses directly attributable to Travelan and Protectyn activities. The Research and Development segment refers to the group’s R&D projects performed in Australia and United States. The company was founded on January 13, 1994, and is headquartered in Blackburn, Australia.
Year: 2007
Sector Update: Healthcare Stocks Decline Late Afternoon
Sep 4, 7:48 PM · MT Newswires
Immuron Signs Exclusive US Distribution Deal for Digestive-Health Product PROIBS
Sep 4, 5:51 PM · MT Newswires
Sector Update: Healthcare Stocks Decline Friday Afternoon
Sep 4, 5:41 PM · MT Newswires
Top Midday Gainers
Sep 4, 5:16 PM · MT Newswires
Top Premarket Gainers
Sep 4, 11:04 AM · MT Newswires
Stay on top of IMRN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
